• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023

    8/1/23 11:00:35 AM ET
    $AEO
    $APLS
    $BA
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AEO alert in real time by email

    Upgrades

    According to Northcoast Research, the prior rating for Boeing Co (NYSE:BA) was changed from Sell to Neutral. In the second quarter, Boeing showed an EPS of $0.82, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $240.13 and a 52-week-low of $120.99. Boeing closed at $238.85 at the end of the last trading period.

    For Varonis Systems Inc (NASDAQ:VRNS), Craig-Hallum upgraded the previous rating of Hold to Buy. Varonis Systems earned $0.01 in the second quarter, compared to $0.00 in the year-ago quarter. The current stock performance of Varonis Systems shows a 52-week-high of $32.05 and a 52-week-low of $15.61. Moreover, at the end of the last trading period, the closing price was at $28.70.

    Atlantic Equities upgraded the previous rating for The Goldman Sachs Group Inc (NYSE:GS) from Underweight to Neutral. For the second quarter, Goldman Sachs Gr had an EPS of $3.08, compared to year-ago quarter EPS of $7.73. The current stock performance of Goldman Sachs Gr shows a 52-week-high of $389.43 and a 52-week-low of $287.84. Moreover, at the end of the last trading period, the closing price was at $355.87.

    For ResMed Inc (NYSE:RMD), RBC Capital upgraded the previous rating of Sector Perform to Outperform. For the third quarter, ResMed had an EPS of $1.68, compared to year-ago quarter EPS of $1.32. The current stock performance of ResMed shows a 52-week-high of $247.51 and a 52-week-low of $202.04. Moreover, at the end of the last trading period, the closing price was at $222.35.

    According to Barclays, the prior rating for Gap Inc (NYSE:GPS) was changed from Equal-Weight to Overweight. In the first quarter, Gap showed an EPS of $0.01, compared to $0.44 from the year-ago quarter. The current stock performance of Gap shows a 52-week-high of $15.49 and a 52-week-low of $7.22. Moreover, at the end of the last trading period, the closing price was at $10.30.

    According to Barclays, the prior rating for Tapestry Inc (NYSE:TPR) was changed from Equal-Weight to Overweight. For the third quarter, Tapestry had an EPS of $0.78, compared to year-ago quarter EPS of $0.51. The current stock performance of Tapestry shows a 52-week-high of $47.48 and a 52-week-low of $27.54. Moreover, at the end of the last trading period, the closing price was at $43.15.

    Barclays upgraded the previous rating for Bath & Body Works Inc (NYSE:BBWI) from Equal-Weight to Overweight. Bath & Body Works earned $0.33 in the first quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.55 and a 52-week-low of $30.52. Bath & Body Works closed at $37.06 at the end of the last trading period.

    For American Eagle Outfitters Inc (NYSE:AEO), Barclays upgraded the previous rating of Equal-Weight to Overweight. In the first quarter, American Eagle Outfitters showed an EPS of $0.17, compared to $0.16 from the year-ago quarter. The current stock performance of American Eagle Outfitters shows a 52-week-high of $17.09 and a 52-week-low of $9.46. Moreover, at the end of the last trading period, the closing price was at $14.05.

    See all analyst ratings upgrades.

    Downgrades

    Argus Research downgraded the previous rating for Canadian National Railway Co (NYSE:CNI) from Buy to Hold. In the second quarter, Canadian National Railway showed an EPS of $1.31, compared to $1.51 from the year-ago quarter. The current stock performance of Canadian National Railway shows a 52-week-high of $129.85 and a 52-week-low of $103.81. Moreover, at the end of the last trading period, the closing price was at $121.23.

    According to RBC Capital, the prior rating for New Relic Inc (NYSE:NEWR) was changed from Outperform to Sector Perform. New Relic earned $0.43 in the first quarter, compared to $0.26 in the year-ago quarter. The stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. At the end of the last trading period, New Relic closed at $83.98.

    According to Hovde Group, the prior rating for Valley National Bancorp (NASDAQ:VLY) was changed from Outperform to Market Perform. For the second quarter, Valley Ntl had an EPS of $0.28, compared to year-ago quarter EPS of $0.32. The current stock performance of Valley Ntl shows a 52-week-high of $13.06 and a 52-week-low of $6.38. Moreover, at the end of the last trading period, the closing price was at $10.26.

    William Blair downgraded the previous rating for Symbotic Inc (NASDAQ:SYM) from Outperform to Market Perform. For the third quarter, Symbotic had an EPS of $0.07, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $64.14 and a 52-week-low of $8.75. At the end of the last trading period, Symbotic closed at $63.54.

    Citigroup downgraded the previous rating for Reata Pharmaceuticals Inc (NASDAQ:RETA) from Buy to Neutral. For the first quarter, Reata Pharmaceuticals had an EPS of $1.81, compared to year-ago quarter EPS of $1.33. At the moment, the stock has a 52-week-high of $167.24 and a 52-week-low of $18.47. Reata Pharmaceuticals closed at $165.58 at the end of the last trading period.

    According to Loop Capital, the prior rating for MaxLinear Inc (NASDAQ:MXL) was changed from Buy to Hold. For the second quarter, MaxLinear had an EPS of $0.34, compared to year-ago quarter EPS of $1.11. The current stock performance of MaxLinear shows a 52-week-high of $43.66 and a 52-week-low of $22.25. Moreover, at the end of the last trading period, the closing price was at $24.67.

    According to DA Davidson, the prior rating for Symbotic Inc (NASDAQ:SYM) was changed from Buy to Neutral. For the third quarter, Symbotic had an EPS of $0.07, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $64.14 and a 52-week-low of $8.75. At the end of the last trading period, Symbotic closed at $63.54.

    For New Relic Inc (NYSE:NEWR), Baird downgraded the previous rating of Outperform to Neutral. New Relic earned $0.43 in the first quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. New Relic closed at $83.98 at the end of the last trading period.

    According to Wells Fargo, the prior rating for Chinook Therapeutics Inc (NASDAQ:KDNY) was changed from Overweight to Equal-Weight. Chinook Therapeutics earned $0.85 in the first quarter, compared to $0.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.54 and a 52-week-low of $17.72. Chinook Therapeutics closed at $39.18 at the end of the last trading period.

    According to Cantor Fitzgerald, the prior rating for Rivian Automotive Inc (NASDAQ:RIVN) was changed from Overweight to Neutral. Rivian Automotive earned $1.25 in the first quarter, compared to $1.43 in the year-ago quarter. The stock has a 52-week-high of $40.86 and a 52-week-low of $11.68. At the end of the last trading period, Rivian Automotive closed at $27.64.

    B of A Securities downgraded the previous rating for Apellis Pharmaceuticals Inc (NASDAQ:APLS) from Buy to Neutral. In the second quarter, Apellis Pharmaceuticals showed an EPS of $1.02, compared to $1.46 from the year-ago quarter. The current stock performance of Apellis Pharmaceuticals shows a 52-week-high of $94.75 and a 52-week-low of $24.97. Moreover, at the end of the last trading period, the closing price was at $25.75.

    Deutsche Bank downgraded the previous rating for ZoomInfo Technologies Inc (NASDAQ:ZI) from Buy to Hold. In the second quarter, ZoomInfo Technologies showed an EPS of $0.26, compared to $0.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $51.85 and a 52-week-low of $20.33. ZoomInfo Technologies closed at $25.57 at the end of the last trading period.

    For New Relic Inc (NYSE:NEWR), Credit Suisse downgraded the previous rating of Outperform to Neutral. For the first quarter, New Relic had an EPS of $0.43, compared to year-ago quarter EPS of $0.26. At the moment, the stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. New Relic closed at $83.98 at the end of the last trading period.

    Citigroup downgraded the previous rating for The Estee Lauder Companies Inc (NYSE:EL) from Buy to Neutral. Estee Lauder Cos earned $0.47 in the third quarter, compared to $1.90 in the year-ago quarter. The stock has a 52-week-high of $284.27 and a 52-week-low of $171.93. At the end of the last trading period, Estee Lauder Cos closed at $180.00.

    According to Barclays, the prior rating for Reata Pharmaceuticals Inc (NASDAQ:RETA) was changed from Overweight to Equal-Weight. In the first quarter, Reata Pharmaceuticals showed an EPS of $1.81, compared to $1.33 from the year-ago quarter. The stock has a 52-week-high of $167.24 and a 52-week-low of $18.47. At the end of the last trading period, Reata Pharmaceuticals closed at $165.58.

    Keefe, Bruyette & Woods downgraded the previous rating for SoFi Technologies Inc (NASDAQ:SOFI) from Market Perform to Underperform. In the second quarter, SoFi Techs showed an EPS of $0.06, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.70 and a 52-week-low of $4.25. SoFi Techs closed at $11.45 at the end of the last trading period.

    For Brown & Brown Inc (NYSE:BRO), Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. In the second quarter, Brown & Brown showed an EPS of $0.68, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $72.99 and a 52-week-low of $52.82. At the end of the last trading period, Brown & Brown closed at $70.45.

    For Eastman Chemical Co (NYSE:EMN), Piper Sandler downgraded the previous rating of Overweight to Neutral. For the second quarter, Eastman Chemical had an EPS of $1.99, compared to year-ago quarter EPS of $2.83. At the moment, the stock has a 52-week-high of $102.12 and a 52-week-low of $69.91. Eastman Chemical closed at $85.58 at the end of the last trading period.

    See all analyst ratings downgrades.

    Initiations

    RF Lafferty initiated coverage on Polestar Automotive Holding UK PLC (NASDAQ:PSNY) with a Buy rating. The price target for Polestar Automotive is set to $9.00. For the first quarter, Polestar Automotive had an EPS of $0.01, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $10.11 and a 52-week-low of $3.14. Polestar Automotive closed at $4.48 at the end of the last trading period.

    With an Overweight rating, Cantor Fitzgerald initiated coverage on Health Catalyst Inc (NASDAQ:HCAT). The price target seems to have been set at $16.00 for Health Catalyst. In the first quarter, Health Catalyst showed an EPS of $0.05, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $18.28 and a 52-week-low of $6.41. At the end of the last trading period, Health Catalyst closed at $14.03.

    Seaport Global initiated coverage on TopBuild Corp (NYSE:BLD) with a Buy rating. In the first quarter, TopBuild showed an EPS of $4.36, compared to $3.50 from the year-ago quarter. The current stock performance of TopBuild shows a 52-week-high of $280.67 and a 52-week-low of $140.93. Moreover, at the end of the last trading period, the closing price was at $273.93.

    For Installed Building Products Inc (NYSE:IBP), Seaport Global initiated coverage, by setting the current rating at Buy. Installed Building Prods earned $2.15 in the first quarter, compared to $1.54 in the year-ago quarter. The current stock performance of Installed Building Prods shows a 52-week-high of $150.88 and a 52-week-low of $75.45. Moreover, at the end of the last trading period, the closing price was at $148.02.

    With a Equal-Weight rating, Morgan Stanley initiated coverage on Vivid Seats Inc (NASDAQ:SEAT). The price target seems to have been set at $9.50 for Vivid Seats. Vivid Seats earned $0.15 in the first quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $9.89 and a 52-week-low of $6.29. At the end of the last trading period, Vivid Seats closed at $8.33.

    With a Buy rating, B. Riley Securities initiated coverage on Lilium NV (NASDAQ:LILM). The price target seems to have been set at $3.00 for Lilium. NoneThe stock has a 52-week-high of $3.25 and a 52-week-low of $0.37. At the end of the last trading period, Lilium closed at $1.37.

    See all analyst ratings initiations.

    Get the next $AEO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEO
    $APLS
    $BA
    $BBWI

    CompanyDatePrice TargetRatingAnalyst
    Installed Building Products Inc.
    $IBP
    10/20/2025Sell
    Vertical Research
    Rivian Automotive Inc.
    $RIVN
    10/20/2025$10.00Neutral → Underperform
    Mizuho
    Tapestry Inc.
    $TPR
    10/15/2025$140.00Buy
    BTIG Research
    Apellis Pharmaceuticals Inc.
    $APLS
    10/15/2025$32.00Overweight
    Wells Fargo
    Estee Lauder Companies Inc.
    $EL
    10/13/2025$115.00Neutral → Buy
    Goldman
    Symbotic Inc.
    $SYM
    10/8/2025$38.00Underweight
    Barclays
    Bath & Body Works Inc.
    $BBWI
    10/6/2025$26.00Overweight → Neutral
    Analyst
    Goldman Sachs Group Inc.
    $GS
    10/3/2025$785.00Market Perform
    BMO Capital Markets
    More analyst ratings

    $AEO
    $APLS
    $BA
    $BBWI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SKYCLARYS issued to REATA PHARMACEUTICALS INC

    Submission status for REATA PHARMACEUTICALS INC's drug SKYCLARYS (ORIG-1) with active ingredient OMAVELOXOLONE has changed to 'Approval' on 02/28/2023. Application Category: NDA, Application Number: 216718, Application Classification: Type 1 - New Molecular Entity

    2/28/23 5:14:09 PM ET
    $RETA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEO
    $APLS
    $BA
    $BBWI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Health Catalyst to Announce Third Quarter 2025 Operating Results and Host Conference Call on Monday, November 10, 2025

    SALT LAKE CITY, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2025 operating results on Monday, November 10, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ325." A live audio webcast will be available online at https://ir.healthcatalyst.com/.

    10/20/25 4:18:41 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    CN Announces Executive Changes to COO and CCO Roles

    MONTREAL, Oct. 20, 2025 (GLOBE NEWSWIRE) -- CN (TSX:CNR) (NYSE:CNI) announced today the appointments of Patrick Whitehead as Executive Vice-President and Chief Operating Officer as well as Janet Drysdale as Executive Vice-President and Chief Commercial Officer, effective immediately. Patrick's appointment follows the departure of Derek Taylor from the Company. "Janet and Pat are key drivers of CN's efforts to achieve new levels of operational, commercial and customer service excellence. Their proven cross-functional leadership is instrumental in delivering value for our shareholders and customers. I look forward to working closely with them," said Tracy Robinson, President and Chief Execu

    10/20/25 11:30:00 AM ET
    $CNI
    Railroads
    Industrials

    Vivid Seats Announces Termination of Tax Receivable Agreement and Elimination of Dual-Class Stock Structure

    CHICAGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ:SEAT) ("Vivid Seats"), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today announced that it has entered into a Corporate Simplification Agreement to effect a series of transactions that will simplify its organizational structure, including by eliminating its existing dual-class, umbrella partnership C corporation (Up-C) structure and terminating its Tax Receivable Agreement (the "TRA") in exchange for 403,022 shares of its Class A common stock. The agreement eliminates $6 million of cash payments

    10/20/25 7:00:53 AM ET
    $SEAT
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AEO
    $APLS
    $BA
    $BBWI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, AFP, Mfg., WWEC & HSE Smith Brian Travis bought $119,595 worth of shares (1,750 units at $68.34), increasing direct ownership by 12% to 16,732 units (SEC Form 4)

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    8/29/25 4:01:38 PM ET
    $EMN
    Major Chemicals
    Industrials

    Director Obrien James J /Ky bought $99,776 worth of shares (1,450 units at $68.81), increasing direct ownership by 27% to 6,828 units (SEC Form 4)

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    8/28/25 4:14:09 PM ET
    $EMN
    Major Chemicals
    Industrials

    Director Mink Kim Ann bought $100,601 worth of shares (1,450 units at $69.38), increasing direct ownership by 104% to 2,840 units (SEC Form 4)

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    8/28/25 4:13:44 PM ET
    $EMN
    Major Chemicals
    Industrials

    $AEO
    $APLS
    $BA
    $BBWI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vertical Research initiated coverage on Installed Building Products

    Vertical Research initiated coverage of Installed Building Products with a rating of Sell

    10/20/25 3:33:33 PM ET
    $IBP
    Homebuilding
    Consumer Discretionary

    Rivian Automotive downgraded by Mizuho with a new price target

    Mizuho downgraded Rivian Automotive from Neutral to Underperform and set a new price target of $10.00

    10/20/25 8:38:14 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    BTIG Research initiated coverage on Tapestry with a new price target

    BTIG Research initiated coverage of Tapestry with a rating of Buy and set a new price target of $140.00

    10/15/25 8:32:52 AM ET
    $TPR
    Apparel
    Consumer Discretionary

    $AEO
    $APLS
    $BA
    $BBWI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Ladensohn David A sold $1,004,974 worth of shares (13,500 units at $74.44) (SEC Form 4)

    4 - Symbotic Inc. (0001837240) (Issuer)

    10/17/25 4:59:17 PM ET
    $SYM
    Industrial Machinery/Components
    Industrials

    Chief Strategy Officer Boyd William M Iii sold $199,720 worth of shares (2,660 units at $75.08), decreasing direct ownership by 9% to 26,769 units (SEC Form 4)

    4 - Symbotic Inc. (0001837240) (Issuer)

    10/17/25 4:59:04 PM ET
    $SYM
    Industrial Machinery/Components
    Industrials

    General Counsel Watson David O. sold $126,100 worth of shares (5,000 units at $25.22), decreasing direct ownership by 4% to 113,730 units (SEC Form 4)

    4 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)

    10/17/25 4:15:08 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEO
    $APLS
    $BA
    $BBWI
    SEC Filings

    View All

    SEC Form 8-K filed by Vivid Seats Inc.

    8-K - Vivid Seats Inc. (0001856031) (Filer)

    10/20/25 7:16:28 AM ET
    $SEAT
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Brown & Brown Inc. filed SEC Form 8-K: Leadership Update

    8-K - BROWN & BROWN, INC. (0000079282) (Filer)

    10/20/25 6:30:27 AM ET
    $BRO
    Specialty Insurers
    Finance

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    10/17/25 5:25:17 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $AEO
    $APLS
    $BA
    $BBWI
    Leadership Updates

    Live Leadership Updates

    View All

    Divcon Controls Names Marc Shiffman CEO

    With two decades of experience managing companies to exceptional results, Shiffman is well qualified to lead Divcon through a rapid phase of growth Divcon Controls ("Divcon"), a global systems integrator delivering facility management automation and monitoring solutions to the world's biggest mission-critical data center operators, announced today that Marc Shiffman has become its new Chief Executive Officer and has joined the company's Board of Directors. Mr. Shiffman joins Divcon with extensive experience in technology and services leadership, having successfully run multiple companies as an operationally adept executive in partnership with innovative founders. Most recently, Mr. Shif

    10/14/25 7:04:00 AM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    Eastman Schedules Third-Quarter 2025 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information

    Eastman Chemical Company (NYSE:EMN): Financial Results Release:     Monday, Nov. 3, 2025 Approximately 4:15 p.m. Eastern Time Via wire distribution and www.eastman.com, News Center and SEC Form 8-K filing.     Advance Slides, Webcast and Teleconference:     Tuesday, Nov. 4, 2025 8:00 a.m. Eastern Time Via listen-only live webcast and teleconference. Advance slides and prepared remarks: posted Monday, Nov. 3, evening at investors.eastman.com Webcast: Eastman Q3 2025 Webcast to join live webcast Teleconference: Toll-Free dial-in number +1 (833) 470-1428 Passcode: 369653   Teleconference Pre-Registration:  

    10/6/25 4:15:00 PM ET
    $EMN
    Major Chemicals
    Industrials

    Healthmine Appoints Dwight Erskine as New Chief Executive Officer

    Healthmine, a leading member engagement and rewards platform for health plans, today announced that its Board of Directors has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine succeeds Bryce Williams, who will remain with the company during a transition period before moving into an advisory role. Erskine joins Healthmine as a seasoned leader with more than 25 years of experience in healthcare technology, transformation and analytics. He most recently served as Senior Vice President of Enterprise Transformation at VillageMD where he led the streamlining of clinical operations and scale value-based care delivery across the organization. Prio

    9/24/25 8:30:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $AEO
    $APLS
    $BA
    $BBWI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/10/24 6:06:03 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:41 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:28 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    $AEO
    $APLS
    $BA
    $BBWI
    Financials

    Live finance-specific insights

    View All

    Health Catalyst to Announce Third Quarter 2025 Operating Results and Host Conference Call on Monday, November 10, 2025

    SALT LAKE CITY, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2025 operating results on Monday, November 10, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ325." A live audio webcast will be available online at https://ir.healthcatalyst.com/.

    10/20/25 4:18:41 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    The Estée Lauder Companies to Webcast Discussion of Fiscal 2026 First Quarter Results on October 30, 2025

    The Estée Lauder Companies Inc. (NYSE:EL) will release its fiscal 2026 first quarter results on October 30, 2025. On that date, at 8:30 a.m. (ET), the Company will provide a live webcast of its conference call and presentation discussing the results, future prospects and recent corporate developments. Stéphane de La Faverie, President and CEO, and Akhil Shrivastava, EVP and CFO, will host the call. Those wishing to access the webcast can visit http://www.elcompanies.com/investors. The call will be archived on the Company's website. The Estée Lauder Companies Inc. is one of the world's leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care pr

    10/16/25 4:45:00 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 Financial Results

    Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 F, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) today announced that the company will host a conference call and webcast to discuss its third quarter 2025 financial results on Thursday, October 30, 2025, at 8:30 a.m. ET. To access the live call by phone, please pre-register for the call here. A live audio webcast of the event and accompanying slides may also be accessed through the "Events and Presentations" page of the "Investors and Media" section of the company's website. A replay of the webcast will be available for 90 days following the event. About Ape

    10/16/25 7:00:00 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care